Literature DB >> 15793583

Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.

Christian Wolfrum1, Matthew N Poy, Markus Stoffel.   

Abstract

High-density lipoproteins (HDLs) are considered antiatherogenic because they mediate reverse cholesterol transport from the periphery to the liver for excretion and degradation. Here we show that mice deficient in apolipoprotein M (apoM), a component of the HDL particle, accumulated cholesterol in large HDL particles (HDL(1)) while the conversion of HDL to prebeta-HDL was impaired. Accordingly, apoM-deficient mice lacked prebeta-HDL, a subclass of lipid-poor apolipoproteins that serves as a key acceptor of peripheral cellular cholesterol. This deficiency led to a markedly reduced cholesterol efflux from macrophages to apoM-deficient HDL compared to normal HDL in vitro. Overexpression of apoM in Ldlr(-/-) mice protected against atherosclerosis when the mice were challenged with a cholesterol-enriched diet, showing that apoM is important for the formation of prebeta-HDL and cholesterol efflux to HDL, and thereby inhibits formation of atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793583     DOI: 10.1038/nm1211

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  101 in total

Review 1.  The effect of chronic kidney disease on lipid metabolism.

Authors:  Neris Dincer; Tuncay Dagel; Baris Afsar; Adrian Covic; Alberto Ortiz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2018-12-05       Impact factor: 2.370

2.  Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus.

Authors:  Mingxia Liu; Cecilia Frej; Carl D Langefeld; Jasmin Divers; Donald W Bowden; J Jeffrey Carr; Abraham K Gebre; Jianzhao Xu; Benny Larsson; Björn Dahlbäck; Barry I Freedman; John S Parks
Journal:  J Lipid Res       Date:  2019-05-27       Impact factor: 5.922

Review 3.  Give me A5 for lipoprotein hydrolysis!

Authors:  Martin Merkel; Joerg Heeren
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  Association of apolipoprotein M gene polymorphisms with ischemic stroke in a Han Chinese population.

Authors:  Dongxue Zhao; Zhiyi He; Xue Qin; Lei Li; Fang Liu; Shumin Deng
Journal:  J Mol Neurosci       Date:  2010-09-25       Impact factor: 3.444

Review 5.  Plasma lipoproteins: genetic influences and clinical implications.

Authors:  Robert A Hegele
Journal:  Nat Rev Genet       Date:  2009-01-13       Impact factor: 53.242

6.  Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans.

Authors:  Allison B Andraski; Sasha A Singh; Lang Ho Lee; Hideyuki Higashi; Nathaniel Smith; Bo Zhang; Masanori Aikawa; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-26       Impact factor: 8.311

7.  alpha(1)-fetoprotein transcription factor (FTF)/liver receptor homolog-1 (LRH-1) is an essential lipogenic regulator.

Authors:  Zhumei Xu; Lingli Ouyang; Antonio Del Castillo-Olivares; William M Pandak; Gregorio Gil
Journal:  Biochim Biophys Acta       Date:  2009-12-28

8.  Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate.

Authors:  Iryna Sutter; Rebekka Park; Alaa Othman; Lucia Rohrer; Thorsten Hornemann; Markus Stoffel; Olivier Devuyst; Arnold von Eckardstein
Journal:  J Lipid Res       Date:  2014-06-20       Impact factor: 5.922

9.  Common variants at the promoter region of the APOM confer a risk of rheumatoid arthritis.

Authors:  Hae Jin Hu; Eun Heui Jin; Seon Hee Yim; So Young Yang; Seung Hyun Jung; Seung Hun Shin; Wan Uk Kim; Seung Cheol Shim; Tai Gyu Kim; Yeun Jun Chung
Journal:  Exp Mol Med       Date:  2011-11-30       Impact factor: 8.718

10.  Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data.

Authors:  C Brorsson; N T Hansen; K Lage; R Bergholdt; S Brunak; F Pociot
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.